0001209191-13-014697.txt : 20130306
0001209191-13-014697.hdr.sgml : 20130306
20130306191959
ACCESSION NUMBER: 0001209191-13-014697
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130302
FILED AS OF DATE: 20130306
DATE AS OF CHANGE: 20130306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glenn Gregory M
CENTRAL INDEX KEY: 0001342823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 13671165
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD, #250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9920 BELWARD CAMPUS DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 9920 BELWARD CAMPUS DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-03-02
0
0001000694
NOVAVAX INC
NVAX
0001342823
Glenn Gregory M
9920 BELWARD CAMPUS DRIVE
ROCKVILLE
MD
20850
0
1
0
0
Chief Scientific Officer
Options-right to buy
1.83
2013-03-02
4
A
0
150000
1.83
A
2023-03-02
Common Stock
150000
714000
D
Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.
/s/ John Herrmann, Attorney-in-fact for Gregory M. Glenn
2013-03-06